163 related articles for article (PubMed ID: 15328105)
1. Genes required for intrinsic multidrug resistance in Mycobacterium avium.
Philalay JS; Palermo CO; Hauge KA; Rustad TR; Cangelosi GA
Antimicrob Agents Chemother; 2004 Sep; 48(9):3412-8. PubMed ID: 15328105
[TBL] [Abstract][Full Text] [Related]
2. The polyketide synthase-associated multidrug tolerance in Mycobacterium intracellulare clinical isolates.
Matsunaga I; Maeda S; Nakata N; Fujiwara N
Chemotherapy; 2012; 58(5):341-8. PubMed ID: 23171694
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.
Danelishvili L; Wu M; Young LS; Bermudez LE
Antimicrob Agents Chemother; 2005 Sep; 49(9):3707-14. PubMed ID: 16127044
[TBL] [Abstract][Full Text] [Related]
5. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
6. Identification of Mycobacterium avium DNA sequences that encode exported proteins by using phoA gene fusions.
Carroll JD; Wallace RC; Keane J; Remold HG; Arbeit RD
Tuber Lung Dis; 2000; 80(3):117-30. PubMed ID: 10970760
[TBL] [Abstract][Full Text] [Related]
7. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
8. The largest open reading frame (pks12) in the Mycobacterium tuberculosis genome is involved in pathogenesis and dimycocerosyl phthiocerol synthesis.
Sirakova TD; Dubey VS; Kim HJ; Cynamon MH; Kolattukudy PE
Infect Immun; 2003 Jul; 71(7):3794-801. PubMed ID: 12819062
[TBL] [Abstract][Full Text] [Related]
9. Identification of virulence determinants of Mycobacterium avium that impact on the ability to resist host killing mechanisms.
Li YJ; Danelishvili L; Wagner D; Petrofsky M; Bermudez LE
J Med Microbiol; 2010 Jan; 59(Pt 1):8-16. PubMed ID: 19745033
[TBL] [Abstract][Full Text] [Related]
10. Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.
Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
J Antimicrob Chemother; 2015 Oct; 70(10):2838-43. PubMed ID: 26142475
[TBL] [Abstract][Full Text] [Related]
11. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis.
Colangeli R; Helb D; Vilchèze C; Hazbón MH; Lee CG; Safi H; Sayers B; Sardone I; Jones MB; Fleischmann RD; Peterson SN; Jacobs WR; Alland D
PLoS Pathog; 2007 Jun; 3(6):e87. PubMed ID: 17590082
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M. avium complex.
Takii T; Abe C; Tamura A; Ramayah S; Belisle JT; Brennan PJ; Onozaki K
J Interferon Cytokine Res; 2001 Mar; 21(3):187-96. PubMed ID: 11331042
[TBL] [Abstract][Full Text] [Related]
14. Identification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides.
Motamedi N; Danelishvili L; Bermudez LE
J Med Microbiol; 2014 Jul; 63(Pt 7):923-930. PubMed ID: 24836414
[TBL] [Abstract][Full Text] [Related]
15. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Sato K; Ogasawara K; Akaki T; Tomioka H
Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
17. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
Kuwabara K; Watanabe Y; Wada K; Tsuchiya T
Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
19. Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection.
Danelishvili L; Wu M; Stang B; Harriff M; Cirillo SL; Cirillo JD; Bildfell R; Arbogast B; Bermudez LE
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11038-43. PubMed ID: 17578930
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
